🇺🇸 FDA

Drug profile · INN

ganciclovir sodium

GANCICLOVIR SODIUM

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

ganciclovir sodium (GANCICLOVIR SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

Key facts

INN ganciclovir sodium
Brand GANCICLOVIR SODIUM
Route INJECTION
Formulation INJECTABLE
Originator Regeneron Ireland Designated Activity Company (DAC)

Frequently asked questions

What is ganciclovir sodium?

ganciclovir sodium (GANCICLOVIR SODIUM) is an FDA-listed pharmaceutical active ingredient. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.

What is the brand name for ganciclovir sodium?

GANCICLOVIR SODIUM is a marketed brand name for ganciclovir sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of ganciclovir sodium?

ganciclovir sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.